• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    More On P31.SI

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Pharmesis International Ltd. (P31.SI)

    -SES
    0.03 Down 0.00(2.86%) Jul 31, 2:12AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Pharmesis International Ltd.
    No. 8 Yingbin Road
    Chengdu,
    China - Map
    Website: http://www.pharmesis.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    Pharmesis International Ltd., an investment holding company, develops, manufactures, and sells western medicines, and traditional Chinese medicines (TCM) in the People’s Republic of China. It operates through three segments: Western Drugs, TCM Formulated Drugs, and Distribution. The company’s pharmaceutical products include prescribed products and over-the-counter drugs. It offers pharmaceutical products in the form of tablets, granules, pills, etc. The company offers Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Gansu for use in treating acute and chronic hepatitis; Er Ding Granules for the treatment of jaundice, as well as clears heat toxin; and Xiao Shi Jian Pi for use in treating flatus, inappetency, dyspepsy, and spleen weakness. It also provides ShuLingHou tablets used in the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Lianpu Shuangqing for use in treating acute inflammation, such as dysentery and intestinal infection; Xiaoluotong Jiaonang for the treatment of rheumatoid arthritis and other rheumatic diseases; and Afenka for use in treating of migraine, relieves pain from headache, cold, nasosinusitis, muscle pain, menstrual pain, toothache, and arthritis. The company markets its western drugs under the Kinna brand name; and TCM formulated drugs under the Longlife brand name to hospitals. In addition, it engages in the wholesale of chemical drugs, biological raw products, TCM products, antibiotics, and antibiotics agents. Pharmesis International Ltd. was founded in 1996 and is headquartered in Chengdu, the People’s Republic of China.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Pharmesis International Ltd.

    Key Executives 
     PayExercised
    Mr. Xuedan Wu , 52
    Chief Exec. Officer and Exec. Director
    214.00KN/A
    Mr. Yun Jiang , 52
    Exec. Chairman and Member of Nominating Committee
    N/AN/A
    Ms. Siaw Yean Tee , 39
    Financial Controller
    N/AN/A
    Dr. Deng Zemin ,
    Head of Research
    N/AN/A
    Ms. Siew Tian Low ACIS,
    Joint Company Sec.
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in SGD.